Mehmet Ali Ergun
Mehmet Ali Ergun
Assistant Professor, Industrial Engineering, İstanbul Technical University
Verified email at
Cited by
Cited by
Collaborative modeling of the benefits and harms associated with different US breast cancer screening strategies
JS Mandelblatt, NK Stout, CB Schechter, JJ Van Den Broek, DL Miglioretti, ...
Annals of internal medicine 164 (4), 215-225, 2016
Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012
SK Plevritis, D Munoz, AW Kurian, NK Stout, O Alagoz, AM Near, SJ Lee, ...
Jama 319 (2), 154-164, 2018
Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality
D Munoz, AM Near, NT Van Ravesteyn, SJ Lee, CB Schechter, O Alagoz, ...
Journal of the National Cancer Institute 106 (11), dju289, 2014
Tailoring breast cancer screening intervals by breast density and risk for women aged 50 years or older: collaborative modeling of screening outcomes
A Trentham-Dietz, K Kerlikowske, NK Stout, DL Miglioretti, CB Schechter, ...
Annals of internal medicine 165 (10), 700-712, 2016
Impact of the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling
O Alagoz, KP Lowry, AW Kurian, JS Mandelblatt, MA Ergun, H Huang, ...
JNCI: Journal of the National Cancer Institute 113 (11), 1484-1494, 2021
The University of Wisconsin breast cancer epidemiology simulation model: an update
O Alagoz, MA Ergun, M Cevik, BL Sprague, DG Fryback, RE Gangnon, ...
Medical decision making 38 (1_suppl), 99S-111S, 2018
Effect of time to diagnostic testing for breast, cervical, and colorectal cancer screening abnormalities on screening efficacy: a modeling study
CM Rutter, JJ Kim, RGS Meester, BL Sprague, EA Burger, AG Zauber, ...
Cancer Epidemiology, Biomarkers & Prevention 27 (2), 158-164, 2018
Using active learning for speeding up calibration in simulation models
M Cevik, MA Ergun, NK Stout, A Trentham-Dietz, M Craven, O Alagoz
Medical Decision Making 36 (5), 581-593, 2016
Comparing CISNET breast cancer incidence and mortality predictions to observed clinical trial results of mammography screening from ages 40 to 49
JJ van den Broek, NT van Ravesteyn, JS Mandelblatt, H Huang, ...
Medical Decision Making 38 (1_suppl), 140S-150S, 2018
Benefits and harms of mammography screening for women with Down syndrome: a collaborative modeling study
O Alagoz, A Hajjar, S Chootipongchaivat, NT van Ravesteyn, JM Yeh, ...
Journal of general internal medicine 34, 2374-2381, 2019
Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer
A Hajjar, MA Ergun, O Alagoz, M Rampurwala
PloS one 14 (6), e0217778, 2019
Using collaborative simulation modeling to develop a web-based tool to support policy-level decision making about breast cancer screening initiation age
ES Burnside, SJ Lee, C Bennette, AM Near, O Alagoz, H Huang, ...
MDM policy & practice 2 (2), 2381468317717982, 2017
Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening
A Trentham-Dietz, MA Ergun, O Alagoz, NK Stout, RE Gangnon, ...
Breast cancer research and treatment 168, 229-239, 2018
Optimal breast cancer risk reduction policies tailored to personal risk level
MA Ergun, A Hajjar, O Alagoz, M Rampurwala
Health Care Management Science 25 (3), 363-388, 2022
Prediction Modeling
N Alkan, Y Turgut, E Ari, S Ata, MY Ulukus, MA Ergun, OF Beyca
Business Analytics for Professionals, 49-112, 2022
Manufacturing Analytics
N Alkan, D Oruc, A Gulbiter, MA Ergun
Business Analytics for Professionals, 457-481, 2022
Impact of disruptions in breast cancer control due to the COVID-19 pandemic on breast cancer mortality in the United States: Estimates from collaborative simulation modeling.
O Alagoz, KP Lowry, AW Kurian, JS Mandelblatt, MA Ergun, H Huang, ...
Journal of Clinical Oncology 39 (15_suppl), 6562-6562, 2021
The system can't perform the operation now. Try again later.
Articles 1–17